Zilara
Whole-plant wellness, made in Cincinnati
Good paperwork, a live disease taxonomy, and no income disclosure.
Can you actually make money with Zilara?
No. Zilara has not published a single earnings figure for this brand. Its own Policies, section 4.6, say an income disclosure exists and that a copy must be handed over every time the plan is shown or an income claim is made. That document is not linked from the earn page and is not at any usual address. Without it, nobody can say what a typical Zilara consultant takes home, and the plan's rates alone cannot answer that.
The plan pays on product orders. Retail Rewards pay 30% of business volume on orders from customers you refer, with no volume, rank or team required. Above that sit a 2x15 matrix, a binary paying $10 a cycle, STAR credits, a Leadership Match and rank bonuses. Joining costs nothing. Staying eligible does: 10 BV of your own orders opens the matrix, 50 adds the binary, and 100 opens the rest, about $100-$130 every rolling 31 days. An unqualified position is compressed, and what it would have earned passes to the next qualified person above it.
The closest numbers come from the two brands this company ran before. Heart & Body Naturals said 86% of its member accounts in 2020 were customers with "no interest in participating". goDesana said 92% of its 2024 purchasers were wholesale customers who "do not participate". Neither gave a median or the share who earned nothing. goDesana counted ranks only among leaders, so its 6% at Diamond is 6% of the 7% who were consultants (our arithmetic: 0.42% of all accounts). The printed matrix needs 65,534 people ordering monthly to fill, and level fifteen holds half its income.
The good parts are real, and better than most. Enrollment is free, with no kit and no franchise fee. The 30% retail rate needs no qualification, so selling to customers does not require a team. Every row of the published matrix table checks out to the cent. Binary volume carries over and does not flush while the account is active. The Policies spell out the FTC 70% rule, ban buying to qualify for rank, give customers sixty days to return with no restocking fee, and give resigning consultants a 90% buyback for twelve months.
Enrollment is genuinely free - no fee, no starter kit, and the Policies confirm there is no franchise fee. The cost is in qualification. Ten BV of monthly personal volume unlocks retail and the matrix, fifty adds the binary, and one hundred adds STAR credits, the Leadership Match and rank bonuses. Qualification runs on a rolling 31-day window, unqualified positions are compressed and their earnings pass upward, and the Member Rewards discount ladder resets to its 5% starting tier if a standing auto-delivery lapses. "Free to join" is accurate and is not the price of participating.
- An income disclosure for Zilara itself, the one section 4.6 of its own Policies says exists. To settle the question it would need a median and the share of consultants who earned nothing, the two figures neither predecessor disclosure reported and the ones the BBB direct-selling guidance names as the ones that matter.
- Eligibility that does not run on your own buying. Right now the full set of streams needs 100 BV of personal orders every rolling 31 days, about $100-$130, and the Member Rewards discount falls back to its 5% starting tier if a standing auto-delivery lapses.
- Published proof that consultants reach real customers at scale. Covering one month at the full tier takes about $350-$430 of customer orders at the 30% retail rate, on the report's breakeven figures, and no Zilara document shows how many consultants sell that much.
- A price and a volume figure on every product. The whole qualification ladder is counted in BV, yet volume is left off individual product pages, and the GOGOStix line of twelve formulas carries no published price or CV anywhere on the public site.
- Product copy a consultant can repeat without breaking the company's own section 3.2. The Black Seed Oil page uses treatment language that rule forbids, product names such as Lyme Support and Thyroid Reset name conditions, and the sister site the same company runs indexes products under Cancer.
That call is computed, not chosen - the rule reads three of the nine published dimension scores and is printed on the methodology page. It describes this company's plan and the figures it publishes about the people already in it. It is not a prediction about you, and nothing on this site is advice.
Legal status
No FDA warning letter, FTC action, state attorney-general action or court case naming Green Organics, Zilara, goDesana, Heart & Body Naturals or Paula Scarcella was located in any database searched. Both Ohio entities are Active on the state register, with Paula Scarcella as statutory agent. Both Kentucky registrations are Inactive and in Bad standing with no annual report ever filed.
Confidence: Medium-High
Primary sources fetched directly where possible. Everything we could not verify is listed at the bottom of this page by name.
Follow the money
A fifteen-year-old Ohio supplement and essential-oil manufacturer that consolidated two of its own MLM brands under a new flagship name in May 2026.
Green Organics, LLC is the single corporate operator. Zilara is the flagship; goDesana (essential oils) and Heart & Body Naturals (supplements) are described in the Policies as "heritage" brands. Nothing was shut down - all three sites remain live today.
The rebrand is commonly described as a chain, goDesana to Heart & Body Naturals to Zilara. It is not. goDesana and Heart & Body Naturals ran concurrently as two separate brands for roughly eight years and were consolidated, not succeeded.
The compensation plan is a hybrid: 30% retail commission with no qualification, a 2x15 matrix paying 5% per level, a binary paying 10% of the weaker leg per cycle, plus a generational match, STAR credits and rank bonuses.
Enrollment is free. Earning on every stream requires roughly $100-$130 of personal orders every rolling 31 days.
Where a $100 order goes, on the plan Zilara publishes
Built only from rates the company states in its own compensation overview, dated 05/2026. Retail Rewards pay 30% of business volume on a personally referred customer order and require no qualification. The Community matrix pays 5% per level on the first 10 BV of each order. The binary pays $10 per cycle, which is 10% of the weaker leg on the 100 BV that triggers it. Zilara does not publish an aggregate payout ratio, so the residual here is the arithmetic remainder - company margin, cost of goods, fulfillment and the rank bonuses and match that are not per-order rates - and not a figure the company has stated. It should not be read as profit.
| Product | Price | Pays |
|---|---|---|
| 3 Pillars membership equivalent - there is none Unlike many programs in this corpus, Zilara sells no membership, no tools subscription and no education package. Every dollar a participant spends buys physical product. This is a genuine structural point in its favor and is why the securities dimension scores at the ceiling. |
n/a n/a |
n/a |
| Black Seed Oil (1 oz) Claims "a minimum of 5% thymoquinone". Peer-reviewed screening of eleven commercial Nigella sativa products found a maximum of 0.81%. The claim is 6.2x the measured commercial ceiling and no per-serving figure is published. Page copy says the oil helps "manage inflammation" and asks what "medicinal constituents" are present. |
$25.95, or $69.95 buy-three-get-one one-time or auto-delivery |
CV not published on the product page |
| Fulvic Minerals (80 servings) At roughly 5.4x a comparable mainstream ionic fulvic product, this is the widest price gap in the catalog, though differing serving sizes make the multiple the softest of the three compared. |
$119.00, or $329.00 buy-three-get-one one-time or auto-delivery |
100 CV |
| Oil of Oregano (1 oz) Roughly 1.7 to 2.0 times a comparable NOW Foods bottle at mainstream retail - an ordinary direct-selling premium rather than an outlier. |
$29.95 one-time or auto-delivery |
CV not published on the product page |
| Essiac Tea (30 servings) A new Zilara SKU with no predecessor-brand equivalent in the archive. The copy is carefully scrubbed - zero mentions of tumor, Caisse or Ojibwa, and the only instance of the word cancer on the page is in the caution list. The exposure is the name: Essiac has an established public identity as an alternative cancer remedy. |
$14.95 one-time or auto-delivery |
CV not published on the product page |
| Protocol kits (Lyme Support, Thyroid Reset, Parasite Detox, Petrochemical Detox, GLP-1 Three Step System) The names are the finding. Lyme names an infectious disease, Thyroid Reset asserts action on an endocrine organ, and GLP-1 invokes a prescription drug class. Under FDA practice a product name establishes intended use. |
$59.95 to $179.95 one-time or auto-delivery |
100-125 CV |
| GOGOStix pocket inhalers (twelve formulas incl. Migraine Ease, Nausea Rescue) An entire product line with no published price and no published CV anywhere on the public site - the single largest pricing-disclosure gap in the catalog. |
not published not published |
not published |
Who runs it, and what they ran before
Named on the Zilara founder page as having founded Green Organics in 2011, written in the first person and signed "~ Paula". She is the statutory agent of record on both Ohio entities - appointed to Green Organics, LLC in October 2016 and named on Green Organics International, LLC from its 2012 formation - and the registered agent on the Kentucky Heart & Body Naturals filing. In 2010, the year before Green Organics, she owned CycleForWealth - a $49.95 two-by-two matrix cycler whose own FAQ page stated "CycleForWealth is owned by Paula Scarcella" in three separate archived captures.
Listed as a Founder on the live Heart & Body Naturals company page and as Vice President on the goDesana BBB profile. He does not appear anywhere on the Zilara founder page.
Billed as "Founder/Formulator" on the live Heart & Body Naturals company page but absent from the Zilara founder page entirely; she survives on Zilara only in the past tense on the heritage page. In 2014 goDesana listed her as "Product Consultant", not a founder. Her Brighton Institute of Botanical Studies exists as two Idaho LLCs, both administratively dissolved.
Registered address
Cincinnati, Ohio
The Policies and Procedures and every live brand site give 754 Cincinnati-Batavia Pike, Suite A, Cincinnati, Ohio 45245, described as a GMP-compliant manufacturing facility. The registered agent addresses on the state filings are different and have moved: the 2011 Articles named a commercial agent firm in Columbus, the 2012 sister entity named the founder in Westerville, the agent moved to Morrow in October 2016, and the lapsed Kentucky registrations used Wilder, Kentucky. "Cincinnati" is where the plant is, not where the entity has historically been registered.
The veteran's checklist
Eight questions that decide whether this is a business or a transfer mechanism. Same eight, every review.
| Question | Answer |
|---|---|
| Is there an income disclosure for this brand? |
RED
No. None is published for Zilara, though the company’s own Policies section 4.6 requires one at every presentation and both predecessor brands published theirs.
|
| Does it cost anything to join? |
OK
No. Enrollment is genuinely free - no fee, no kit, no franchise fee. The cost is the roughly $100-$130 of monthly personal orders needed to earn on every stream.
|
| Can you earn without recruiting? |
OK
Yes, and this is the plan’s best feature. Retail Rewards pay 30% of business volume on personally referred customer orders with no personal volume, rank or team requirement.
|
| Are the products real and shipped? |
OK
Yes. Physical supplements and essential oils, manufactured at the company’s own Cincinnati facility, with plain ingredient lists and a sixty-day refund.
|
| Do the products make disease claims? |
CONCERN
The body copy is careful; the product names are not. Lyme Support, Thyroid Reset, Migraine Ease and a GLP-1 system name conditions and drug classes, which under FDA practice establishes intended use.
|
| Is there a regulatory record? |
OK
None found. No FDA warning letter, FTC action, state AG action or court case naming any of these entities or principals was located in any database searched, including both 2020 FTC COVID warning-letter rounds.
|
| Is the corporate entity in good standing? |
WATCH
In Ohio, yes - both entities are Active on the state register with the founder as statutory agent. In Kentucky, no: both registrations are Inactive and in Bad standing, and neither ever filed an annual report.
|
| Can you get your money back? |
OK
Yes. Sixty days for customers with no restocking fee, and a twelve-month 90% buyback for resigning consultants - at or above what state MLM buyback statutes require.
|
What has to be true for you to get paid
| To cover | You need |
|---|---|
| undefined | undefined undefined |
| undefined | undefined undefined |
| undefined | undefined undefined |
| undefined | undefined undefined |
Read this twice
These are computed from Zilara’s own published rates and thresholds, not from any earnings data, because none is published for this brand. The 30% retail commission with no qualification is the only stream a participant controls directly, and it is the only one that can plausibly cover the monthly qualification cost without an organization. Every other stream depends on other people’s continued purchasing.
Run your own numbers
Drag the sliders. Nothing here is stored or sent.
30% of business volume on a ~$60 average customer order, the one stream that needs no qualification. Cost is the ~$115/mo personal volume needed for the 100 BV tier that unlocks STAR, the Match and rank bonuses. Your own subscription cost of $115/mo is included.
What it costs to replace this yourself
The products are real and a customer who likes them is buying goods, not a position. The comparison that matters is for someone weighing the business: what the same monthly qualifying spend buys elsewhere, and what supplements of the same description cost at ordinary retail. Prices below were fetched 15 September 2026.
| What they sell you | What you'd use instead | Your cost |
|---|---|---|
| $29.95 | $15.29-$17.99 (NOW Foods at mainstream retail) | undefined |
| $119.00 (80 servings) | $21.99 (Trace Minerals ionic fulvic acid) | undefined |
| $25.95 | $28.95 for a larger bottle from the company’s own reseller | undefined |
| ~$100-$130 every 31 days | $0 | undefined |
| none - no independent assay of any product exists | ConsumerLab and Labdoor publish tested results for competing black seed oils | undefined |
| "a GMP-compliant facility" - self-asserted, no certifier named | NSF, USP and third-party certified equivalents are widely available | undefined |
| Total as sold About $1,200-$1,560 a year in qualifying orders to earn on every stream, against a catalog priced at roughly 1.7x to 5.4x mainstream equivalents. |
Total, built yourself About $250-$400 a year buying comparable supplements at ordinary retail, with no qualification requirement and independently tested potency available. |
Price-to-value
If you want the products, buy the products - the 60-day refund and no restocking fee make that a low-risk trial, and a customer owes the company nothing further. The business case is the harder sell: it requires continuous personal purchasing at a premium, against a compensation plan whose earnings record the company has not published for this brand.
Three operators, five horizons
Probability of cumulative net profit
Hover any point for median, top decile and bottom quartile.
The Product Customer
buys at retail, never enrolls as a consultant, and is the outcome the predecessor disclosures show is overwhelmingly the most common - 86% of HBN accounts in 2020 and 92% of goDesana purchasers in 2024 did not participate in the plan
| Horizon | P(profit) | Median |
|---|---|---|
| 3 mo | 92% | -$90 |
| 6 mo | 92% | -$180 |
| 1 yr | 92% | -$360 |
| 3 yr | 92% | -$1,080 |
| 5 yr | 92% | -$1,800 |
The Retail Seller
enrolls free, keeps a 10 BV monthly order, and sells to a handful of real customers on the unqualified 30% retail rate - modeled from published rates, not from any company case study
| Horizon | P(profit) | Median |
|---|---|---|
| 3 mo | 30% | -$120 |
| 6 mo | 24% | -$180 |
| 1 yr | 18% | -$240 |
| 3 yr | 10% | -$300 |
| 5 yr | 7% | -$300 |
The Team Builder
maintains the full 100 BV tier to unlock STAR, the Match and rank bonuses, and recruits actively - modeled from published rates and thresholds, not from any published earnings record
| Horizon | P(profit) | Median |
|---|---|---|
| 3 mo | 12% | -$390 |
| 6 mo | 9% | -$600 |
| 1 yr | 6% | -$800 |
| 3 yr | 3% | -$900 |
| 5 yr | 2% | -$800 |
Methodology note. These are models built from Zilara’s published rates and qualification thresholds, and from the participation rates in the two predecessor brands’ own income disclosures. They are not Zilara earnings data, because Zilara publishes none. The participation percentages carry the most weight and are the best-evidenced numbers here: 86% of Heart & Body Naturals accounts in 2020 and 92% of goDesana purchasers in 2024 were customers who did not participate in the compensation plan at all. Any reader who takes one number from this report should take that one.
Where you are actually allowed to promote this
Platform policy reads, not verifications. Check every one before you spend a dollar - enforcement changes faster than the written policy does.
Red flags and green flags
Red flags
141No income disclosure exists for the flagship brand
2Both predecessor brands published one, and this one did not
3A sister site still indexes products under "Cancer"
4Product names assert disease treatment the copy avoids
5The company’s own pages breach its own section 3.2
6A potency claim 6.2x the measured commercial ceiling
7An impossible credential claim, live today
8The formulator’s institute is two dissolved LLCs
9Both Kentucky registrations lapsed into Bad standing
10The founder ran a matrix cycler the year before founding this company
11"Free to join" understates the cost of earning
12An entire product line has no published price
13Archived predecessor copy tied herbal tea to cancer
14Quality claims are self-asserted with no certifier named
Green flags
101Enrollment is genuinely free
230% retail commission with no qualification whatsoever
3The published compensation arithmetic is correct
4An explicit, correctly-stated FTC 70% rule
5A real bonus-buying prohibition with teeth
6Sixty-day customer refunds and a 90% twelve-month buyback
7Mediation before arbitration, with costs shared
8Consultants may work with other direct-selling companies
9No securities exposure to the participant
10A named operator with a fifteen-year history and its own plant
We would like to be wrong about this
Upward
- Publish an income disclosure for Zilara. The single highest-value change available. Both predecessor brands published one; producing a third with a median and a share-earning-nothing figure would move participant economics materially.
- Retire the disease taxonomy on the sister site. Removing the Cancer, Infectious Disease, Erectile Dysfunction and Depression categories from hbnaturals.com would close the largest health-claim exposure, which currently exists on a live site the same company operates.
- Substantiate or withdraw the thymoquinone and Nieper claims. An independent assay naming the laboratory would settle the 5% claim. The German Cancer Society attribution is falsifiable on public dates and should simply be corrected.
Downward
- A regulator acts on the health claims. An FDA warning letter or FTC action over the product naming or the sister-site taxonomy would move product and marketing conduct to the floor and could cap the grade below the arithmetic.
- The Ohio entities prove to be lapsed as well. Both Kentucky registrations are already Inactive in Bad standing. If the Ohio filings are in similar condition, the ownership dimension has further to fall.
- An assay contradicts the potency claim. If independent testing showed thymoquinone materially below the published minimum, an untested extraordinary claim becomes a substantiated false one, which is a different and much more serious finding.
The products and the business are two different decisions, and they deserve different answers.
If you want the supplements, buy them as a customer and stop there. Sixty days, no restocking fee, and no qualification requirement means a trial costs you the shipping if you dislike them. A customer owes this company nothing further, and the predecessor disclosures show that is what the overwhelming majority of people here actually are - 86% and 92% of accounts in the two brands that published figures.
If you want the business, the honest comparison is against the 30% retail rate alone, because it is the only stream you control. Selling roughly $400 of product a month to real customers covers the qualification cost and leaves something over. That is a real, modest retail business, and the plan permits it with no qualification at all - which is genuinely to the company’s credit. The leveraged streams are a different proposition and depend on other people continuing to buy.
What should give a prospective builder pause is not the plan. It is that the company requires an income disclosure at every presentation and has not published one for this brand, and that the same operator is today running a sister site that indexes its catalog under Cancer and Infectious Disease. You would be the one repeating those claims to your own customers.
Ask for the Income Disclosure Statement in writing
Section 4.6 entitles you to one at every presentation. If a sponsor cannot produce one for Zilara, that is the answer to the income question - and it is the company’s own policy being unmet, not an outside criticism.
Ask what the thymoquinone figure means per serving
The page claims a minimum of 5% but publishes no per-serving dose. A company confident in an extraordinary potency claim can convert it to milligrams and name the lab that measured it.
Price the qualification, not the enrollment
Enrollment is free and irrelevant to the economics. The number that matters is roughly $100-$130 every 31 days, indefinitely, to keep earning on every stream.
Buy as a customer first for sixty days
The refund terms are good and cost you only return shipping. If the products do not justify their price to you as a buyer, they will not justify it to the customers you would need to sell them to.
Nine dimensions, weighted
Dimension profile
Further from center is better. Hover any point.
Hard caps that bind here
The lowest binding cap wins, regardless of the weighted arithmetic.
What we read
Every source below links to the document itself. Tier 1 is a primary record - the company’s own plan, policy or disclosure, a court filing, a regulator’s decision or an SEC filing. Tier 2 is a self-regulatory or secondary regulator record, tier 3 reporting or academic work, tier 4 an open-market price comparison. Where a document can be moved or withdrawn, an archived copy is linked beside it. If a link is dead when you try it, that is a correction we want.
- Zilara Policies and Procedures, effective 15 May 2026 (20pp)
- Zilara Compensation Plan Overview, dated 05/2026
- Zilara Compensation Plan, detailed edition (38pp)
- Zilara Refunds and Returns Policy, effective 15 May 2026
- Zilara Terms of Use
- Zilara Privacy Policy, carrying the Cincinnati-Batavia Pike address
- Zilara Electronic Signature disclosure
- Zilara earn page - the S.A.F.E. plan and its six income streams
- Zilara founder page - Paula Scarcella billed as sole founder
- Zilara heritage page - Brighton as "The Formulator", past tense
- Zilara Black Seed Oil product page - the "minimum of 5% thymoquinone" claim
- Zilara Essiac Tea product page
- Zilara protocols page - Lyme Support, Thyroid Reset, GLP-1 Three Step System
- Zilara detox range and published CV values
- Zilara GOGOStix page - twelve formulas, no published price or CV
- Zilara Member Rewards Program - the autoship-gated discount ladder
- Zilara free account page - "No purchase required"
- Zilara products page - the $49 membership equivalent does not exist
- Heart & Body Naturals formulator page - the Hans Nieper attribution
- Heart & Body Naturals health interests page - the live disease taxonomy
- Heart & Body Naturals company page - three founders listed including Brighton
- Heart & Body Naturals protocols page - Lyme Support and Infectious Disease
- Heart & Body Naturals 2020 Income Disclosure Statement
- goDesana 2024 Income Disclosure Statement
- Kentucky Secretary of State - Heart & Body Naturals LLC, org 1032378, Inactive/Bad
- Kentucky Secretary of State - Green Organics, org 1048784, Inactive/Bad
- CycleForWealth FAQ, February 2010 - "CycleForWealth is owned by Paula Scarcella"
- CycleForWealth FAQ, April 2010 - the same ownership sentence
- CycleForWealth FAQ, June 2010 - the same ownership sentence again
- goDesana executive team, January 2014 - Brighton listed as "Product Consultant"
- goDesana Clear Cellular Health Tea, February 2015 - "treat everything from headaches to cancer"
- Heart & Body Naturals Black Seed Extract, June 2019 - the "3,000mg Thymoquinone" claim
- Heart & Body Naturals Healing Trilogy, July 2018 - the unhedged original wording
- Heart & Body Naturals Healing Trilogy, May 2023 - the same sentences, hedged
- Heart & Body Naturals protocols, September 2024 - the archived disease taxonomy
- Heart & Body Naturals, March 2017 - "what heals also prevents"
- Khaikin et al., screening of thymoquinone in commercial Nigella sativa products, Nutrients 2022
- Memorial Sloan Kettering integrative medicine monograph on Essiac
- FTC warning letters to multi-level marketers on health and earnings claims, April 2020
- FTC second round of warning letters to multi-level marketers, June 2020
- FDA warning letter database - no letter to any of these entities was located
- CourtListener federal docket and opinion search - no case naming these entities or principals
- BBB profile, Heart & Body Naturals LLC - A+, not accredited, one complaint in three years
- BBB profile, goDesana Organics - A+, not accredited, zero complaints
- BBB DSSRC guidance on income disclosures - medians and the share earning nothing
- Trustpilot, hbnaturals.com - 2.8 from five reviews, profile unclaimed
- OpenCorporates, Green Organics LLC, Ohio entity 2051639
- OpenCorporates, Green Organics International LLC, Ohio entity 2146740
- Ohio Secretary of State - Green Organics, LLC, entity 2051639, Active
- Ohio SOS filing 201127700855 - Green Organics, LLC Articles of Organization, 5 October 2011
- Ohio SOS filing 201629502566 - Subsequent Agent Appointment naming Paula Scarcella, 21 October 2016
- Ohio SOS filing 201230001359 - Green Organics International, LLC Articles of Organization, 29 October 2012
- NOW Foods Oregano Oil 1 oz at mainstream retail, for price comparison
- Trace Minerals Ionic Fulvic Acid at manufacturer retail, for price comparison
- Ernst von Leyden and the institutionalization of German cancer research, 1896-1911
- Deutsche Krebsgesellschaft official history - the 1900 founding committee
- Ernst von Leyden (1832-1910), a pioneer in making oncology a respected discipline
What we could not get
- Whether the 5% thymoquinone claim is accurate. No independent assay of any Zilara, goDesana or Heart & Body Naturals product exists, and neither ConsumerLab nor Labdoor has tested one. This report records only that the claim is 6.2x the highest of eleven commercially screened products in the peer-reviewed literature.
- Thymoquinone per serving. No milligram-per-dose figure is published, so the percentage cannot be converted to an intake and compared against a safe-dose ceiling.
- Whether Alexandria Brighton remains involved with the business in 2026. She is absent from the Zilara founder page, present on the heritage page in the past tense, and still billed as Founder/Formulator on the live Heart & Body Naturals company page. No departure statement was found, and the company was not asked.
- Whether Dr Paul Wedel, named in the formulator biography as the origin of the founder-formulator’s training, can be identified. A literature search returned no matching oncologist, while a control search for Nieper returned results, indicating the method works.
- The reason for the May 2026 consolidation. No announcement explaining it was located.
- Whether any pre-2017 FDA warning letter exists. FDA archives letters after five years and neither available index covers earlier material, so the clean FDA finding is bounded to 2017 onward.
- Any state business-opportunity registration. No state exposes a searchable public registry, so this could not be checked and would require written records requests.
Not advice
This is independent analysis for decision-making, not legal, financial or investment advice. Allegations reported by third parties should be verified against primary court and regulatory records before any decision.
Researched by Claude. Reviewed by an editor.
Every report is researched and written by Claude, Anthropic’s AI assistant, from the company’s own plan documents, policies, terms and regulatory file - then reviewed before publication by Rob Fore, who checks the sources and the stage-label on every allegation.
- Nine weighted dimensions, published with their weights
- The editor checks the evidence and cannot change the number - the build rejects any page whose grade does not reconcile to its own arithmetic
- Every affiliate position we hold is disclosed on the report it touches
- No company has paid for a grade, and no report carries an affiliate link
Looking at something else?
Enter any company name or website. If a report exists it opens instantly; if not, we start one.
Zilara - frequently asked
QIs Zilara a pyramid scheme?
QDoes Zilara publish an income disclosure?
QWhat does it cost to join Zilara?
QWho owns Zilara?
QAre Zilara products safe?
Author, editor and publisher
This report was researched and written by Claude, Anthropic’s AI assistant, working from primary documents - Zilara’s own compensation plan, its policies and procedures, its terms of service, its income disclosure statement where one exists, and its regulatory and self-regulatory file. It was scored against nine weighted dimensions that are published in full, with their weights, on the methodology page.
Before publication it was reviewed by Rob Fore, who checks every source link, every figure against the document it came from, and every allegation against its stage-label - an investigation is not a finding, a warning letter is not an enforcement action, and a filed claim is not a verdict.
The editor does not set the grade. The published score is the weighted composite of the nine dimension scores, and the build refuses to emit a page where the two disagree by more than 0.06. A grade moves when the evidence moves it and not otherwise.
Rob Fore has marketed online since 1996, wrote Online MLM Marketing (2014), and is CEO of Listech Inc, the Nevada corporation that publishes this site. He holds affiliate positions in companies graded here - including LiveGood, which this site grades D, SendOutCards, which it grades C−, and the Home Business Academy, which it grades B−. Those positions are disclosed on the reports they touch, and changed nothing on this page.
About the author and our conflicts · Contact the editor · Corrections: corrections@opportunitygrade.com
Tell me if this grade changes
Zilara is graded D as of September 15, 2026. Grades move when the evidence moves - a new income disclosure, a regulatory action, a rewritten compensation plan. Leave your address and you will get one email if this one does.
One email when the grade moves, and nothing else. We will never use your address to promote an income opportunity of any kind, we do not sell, rent or share the list, and it is stored on our own infrastructure rather than with any company graded here. Unsubscribe removes everything.
Corrections
Every factual claim on this page is sourced, and the ones we could not stand up are named in the unable to verify list above. If something here is wrong, we want to know, and we would rather hear it from Zilara than from a reader.
Write to corrections@opportunitygrade.com. Point at the specific sentence and send the document that contradicts it - a plan document, a filing, an income disclosure, a policy page. We will check it against the primary source, correct the page if it is wrong, and keep a dated record of the change. A grade moves if the evidence moves it.
This address reaches a person, not a form. We do not require a takedown demand, an NDA or a lawyer to accept a correction, and we do not remove a report because a company disputes its conclusion - only because the underlying facts turn out to be wrong.